Nadja Uhlig

431 total citations
6 papers, 63 citations indexed

About

Nadja Uhlig is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nadja Uhlig has authored 6 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Nadja Uhlig's work include SARS-CoV-2 and COVID-19 Research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Virus-based gene therapy research (2 papers). Nadja Uhlig is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Virus-based gene therapy research (2 papers). Nadja Uhlig collaborates with scholars based in Germany, United States and Netherlands. Nadja Uhlig's co-authors include Thomas Grünwald, Christian Gege, Gerald Kleymann, Anke Burger‐Kentischer, Klaus Hamprecht, Doris Finkelmeier, Fernando Bravo, David I. Bernstein, Franziska Lange and Leila Issmail and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Science Translational Medicine.

In The Last Decade

Nadja Uhlig

5 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadja Uhlig Germany	4	33	21	16	14	9	6	63
Dilma do Socorro Moraes de Souza Brazil	6	55 1.7×	4 0.2×	5 0.3×	7 0.5×	28 3.1×	19	77
Hugues Flodrops France	4	10 0.3×	11 0.5×	10 0.6×	15 1.1×	6 0.7×	6	63
Chalise E. Carter United States	5	49 1.5×	35 1.7×	9 0.6×	7 0.5×		5	96
Fabíola Scancetti Tavares Brazil	4	23 0.7×	2 0.1×	8 0.5×	3 0.2×	12 1.3×	7	41
Sunil Kumar Verma India	5	25 0.8×	40 1.9×	10 0.6×	2 0.1×	3 0.3×	11	109
Olga Agafitei Canada	3	28 0.8×	14 0.7×	2 0.1×	5 0.4×		3	34
Sungjun Beck United States	6	16 0.5×	23 1.1×	6 0.4×	2 0.1×	29 3.2×	6	86
Nisar Farhat United States	2	22 0.7×	20 1.0×	4 0.3×		3 0.3×	3	51
Sameer Alawadhi United Arab Emirates	2	25 0.8×	7 0.3×	35 2.2×		5 0.6×	4	47
Claire Hartloge United States	3	18 0.5×	18 0.9×	5 0.3×		5 0.6×	4	40

Countries citing papers authored by Nadja Uhlig

Since Specialization

Citations

This map shows the geographic impact of Nadja Uhlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadja Uhlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadja Uhlig more than expected).

Fields of papers citing papers by Nadja Uhlig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadja Uhlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadja Uhlig. The network helps show where Nadja Uhlig may publish in the future.

Co-authorship network of co-authors of Nadja Uhlig

This figure shows the co-authorship network connecting the top 25 collaborators of Nadja Uhlig. A scholar is included among the top collaborators of Nadja Uhlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadja Uhlig. Nadja Uhlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wang, Wenjun, Philipp Arnold, Nadja Uhlig, et al.. (2024). Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2. Communications Biology. 7(1). 865–865.

2.

Gege, Christian, Friedrich Hahn, Christina Wangen, et al.. (2024). Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity. ChemMedChem. 19(19). e202400292–e202400292. 5 indexed citations

3.

Uhlig, Nadja, Zsolt Ruzsics, Sarah Nietzer, et al.. (2024). TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1. SHILAP Revista de lepidopterología. 32(1). 200784–200784. 1 indexed citations

4.

Uhlig, Nadja, Leila Issmail, Sandra Ciesek, et al.. (2023). Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system. Journal of Controlled Release. 364. 654–671. 6 indexed citations

5.

Uhlig, Nadja, et al.. (2021). Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model. Antiviral Research. 195. 105190–105190. 13 indexed citations

6.

Gege, Christian, Fernando Bravo, Nadja Uhlig, et al.. (2021). A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections. Science Translational Medicine. 13(598). 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact